Navigation Links
USP and NIBSC to collaborate on improved quality standards for biological medicines
Date:12/18/2008

Rockville, Md., December 18, 2008 To improve the quality of the rapidly expanding array of biological medicines, the U.S. Pharmacopeial (USP) Convention has entered into a Memorandum of Understanding (MOU) with the National Biological Standards Board, which manages the National Institute for Biological Standards and Control (NIBSC) of the United Kingdom. Biological medicines are made with materials derived from plants or animals, rather than those created in a chemical laboratory. The MOU will help improve and harmonize quality standards for these medications.

"USP is dedicated to improving the health of people around the world through public standards that help ensure the quality, safety and benefit of medicines and foods," said Roger L. Williams, M.D., executive vice president and CEO of USP. "This collaboration with NIBSC is another step in establishing critical partnerships to develop the best quality standards for biological medications as well as for traditional pharmaceuticals."

Specifically, USP and NIBSC are considering the following collaborative activities:

  • Preparation of reference materials for biological products at NIBSC and in USP laboratories;
  • Preparation of reference materials for biologics that are linked with pharmacopeial documentary standards;
  • Collaborative research agreements leading to joint publications and compendial methods; and
  • Mutual availability of scientists to serve and support each organization's committees, education or training programs and meetings.

USP and NIBSC play key roles in the development, characterization and dissemination of reference materials and documentary standards for medicines. Biological materials are an increasingly important means of preventing and treating illness, restoring health and saving livesand this MOU will advance public health through collaboration on improved quality standards for these medicines.


'/>"/>

Contact: Sandra Kim
sek@usp.org
301-816-8241
US Pharmacopeia
Source:Eurekalert

Page: 1

Related medicine news :

1. Pathwork Diagnostics Collaborates With Guys and St Thomas on Tissue of Origin Test Validation in the UK
2. Tibotec and Emcure Collaborate on Access to Darunavir for India
3. Bon Secours, Sentara to Collaborate on Princess Anne Hospital
4. Neuralstem Collaborates with Hospital in Taiwan to Develop Additional ALS Stem Cell Clinical Trials
5. Johns Hopkins and Makerere University to collaborate on African health education initiative
6. Institute on Aging Collaborates With New Program San Francisco Village
7. Zimmer Holdings to Collaborate with the American Orthopaedic Association for Funding Post-Graduate Medical Education
8. ASPH and APHA Collaborate to Shore up the Public Health Workforce Pipeline:
9. Ask.com and American Dietetic Association Collaborate to Help Parents Avoid Sugar-Induced Halloween Hangover in Kids
10. The Cancer Genome Atlas reports first results, Johns Hopkins Kimmel Cancer Center collaborates
11. CollaborateMD Ranks in Top 100 Software Companies on 2008 Inc. 5,000
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Lakes, NJ (PRWEB) , ... December 05, 2016 ... ... recording studio teaming up on new songs with prolific Songwriter-Producer Corey “Chorus” Gibson ... Foxx, Kelly Rowland, Ciara, Brandy…just to name a few.     https://twitter.com/coreychorus , ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... moisture measurements are consistently correct. However, regular performance testing is often neglected ... offers a solution: SmartCal™ . This innovative test substance offers a ...
(Date:12/4/2016)... York, NY (PRWEB) , ... December 03, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – hosted its first Swirl: A Wine Tasting Event in New York ...
(Date:12/4/2016)... ... 04, 2016 , ... "Pro3rd Displace is a set of ... displacement design elements," said Christina Austin - CEO of Pixel Film Studios. ... of design styles that include both left aligned and right aligned options for ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- M ichael Moore ... Chairman   Mission Therapeutics, a drug discovery and ... treat cancer, neurodegenerative and other diseases, announces that Dr ... January 1 st 2017. Dr Colin Goddard ... in July 2015. Michael Moore , Mission,s Founder Chairman, ...
(Date:12/4/2016)... 3, 2016 Johnson & Weaver, LLP announces that ... of Zimmer Biomet Holdings, Inc. (NYSE: ZBH ) ... 31, 2016 (the "Class Period"). Zimmer Biomet provides ... orthopaedic reconstructive products, such as knee and hip reconstructive products. ... , , ...
(Date:12/4/2016)... , Dec. 3, 2016  Results from the ... SelG1), an anti-P-selectin antibody, reduced the median annual rate ... to placebo (1.63 vs 2.98, p=0.010) in patients with ... that the data are being featured in the official ... of Hematology (ASH) Annual Meeting and presented during the ...
Breaking Medicine Technology: